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Abstract
IMPORTANCE—Travelers from around the globe will attend the 2014 Fédération Internationale 
de Football Association (FIFA) World Cup and the 2016 Olympic and Paralympic Games in 
Brazil. Travelers to these mass gathering events may be exposed to a range of health risks, 
including a variety of infectious diseases. Most travelers who become ill will present to their 
primary care physicians, and thus it is important that clinicians are aware of the risks their patients 
encountered.
OBJECTIVE—To highlight health and safety concerns for people traveling to these events in 
Brazil so that health care practitioners can better prepare travelers before they travel and more 
effectively diagnose and treat travelers after they return.
EVIDENCE REVIEW—We reviewed both peer-reviewed and gray literature to identify health 
outcomes associated with travel to Brazil and mass gatherings. Thirteen specific infectious 
diseases are described in terms of signs, symptoms, and treatment. Relevant safety and security 
concerns are also discussed.
FINDINGS—Travelers to Brazil for mass gathering events face unique health risks associated 
with their travel.
CONCLUSIONS AND RELEVANCE—Travelers should consult a health care practitioner 4 to 
6 weeks before travel to Brazil and seek up-to-date information regarding their specific itineraries. 
For the most up-to-date information, health care practitioners can visit the Centers for Disease 
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Control and Prevention (CDC) Travelers’ Health website (http://wwwnc.cdc.gov/travel) or review 
CDC’s Yellow Book online (http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014).
Brazil will host millions of travelers at 3 major mass gathering events: the 2014 Fédération 
Internationale de Football Association (FIFA) World Cup, and the 2016 Olympic Games 
and Paralympic Games.1,2 Mass gathering spose complex public health challenges, and with 
these events being held in the same country within a limited time span, these challenges may 
be exacerbated. Venues are located across Brazil. FIFA’sWorld Cup will be held in 12 cities 
(Figure 1A)1 and the Olympic and Paralympic Games will be located near Rio de Janeiro 
(Figure 1B).2
Mass gatherings have been associated with adverse health events and can increase infectious 
disease transmission because of the influx of travelers, crowding at venues, poor hygiene 
from temporary food and sanitation facilities, challenging security situations, and unfamiliar 
public infrastructure.3-5 During the 2008 World Youth Day in Sydney, Australia, an 
influenza outbreak was caused by at least 6 distinct influenza viruses.6 Meningococcal 
disease outbreaks followed a 1997 football tournament in Belgium7 and the 2000 Hajj in 
Saudi Arabia.8 During the 1996 Atlanta Olympic Games, more than 1000 people received 
health care for heat-related conditions.9
Because the Centers for Disease Control and Prevention (CDC) recommends all travelers 
visit a medical practitioner 4 to 6 weeks prior to travel, we provide information for health 
care practitioners, including an overview of Brazil, relevant medical conditions and 
preventive measures, and general safety and security issues.
Brazil—The Host Country
Brazil is the largest country in South America, covering 8 514 877 km2.10 Brazil has a 
population of more than 200 million; 87% lived in urban areas in 2010. Many host cities for 
events are overcrowded, including São Paulo (approximately 20 million population) and Rio 
de Janeiro (approximately 12 million). Portuguese is the official 
language.10,11Transportation conditions vary throughout Brazil: only 13.5%of roads are 
paved.10 Urban subways are available in São Paulo, Rio de Janeiro, and Recife.11
Infectious Disease Risks for Travelers to Brazil and Disease-Specific 
Prevention Recommendations
Routine Vaccines
Diseases prevented by routine vaccination are prevalent in Brazil. Medical practitioners can 
ensure travelers are current on all routine vaccines (Table 1).
Hepatitis A and B
Hepatitis A, transmitted by food, water, or direct person-to-person contact,16 is 
characterized by any combination of the following symptoms: fever, anorexia, jaundice, 
nausea, vomiting, and abdominal pain. Diagnosis typically involves a compatible clinical 
picture, elevations of hepatic enzyme levels, and detection of IgM antibodies to hepatitis A. 
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Treatment is supportive. Domestic incidence of hepatitis A varies across Brazil and was 
approximately 7.5 to 11 cases per 100 000 persons during 2000 through 2005.17The CDC 
recommends all travelers receive hepatitis A vaccine. The first of the 2-dose series can be 
administered up to departure, providing most travelers adequate protection. For long-term 
protection, the second dose should be given after6months. For those suspected of having had 
illness previously, a serological test for IgG to hepatitis A may be performed prior to 
vaccination.16,18Hepatitis B virus is transmitted through blood or other body fluids.19 Acute 
hepatitis B virus may cause a febrile illness including nausea, vomiting, rashes, joint pain, 
and jaundice; chronic infection can lead to liver disease, including cirrhosis and liver 
cancer.19 Diagnosis involves recognition of the clinical syndrome along with laboratory 
evidence for hepatitis B.20 Treatment of acute illness is supportive. The prevalence of 
chronic carriers of hepatitis B virus in Brazil is 2% to 7%.20 The CDC recommends all 
travelers to Brazil be vaccinated for hepatitis B.19 Travelers should have as many doses of 
the series as possible before travel. An accelerated regimen and a hepatitis A and B 
combined vaccine are available.19,21
Typhoid and Paratyphoid Fever
Typhoid, also a risk for travelers to Brazil, is transmitted via contaminated food or water. 
Symptoms range from fever to more severe disease that includes abdominal pain, headache, 
myalgia, nausea, and anorexia.22 Serious complications include intestinal hemorrhage, 
perforation, or even death.22 Paratyphoid fever is a similar but typically less severe form of 
typhoid fever. Because many patients present with fever and other nondiagnostic 
constitutional symptoms, diagnosis is often difficult. Blood, urine, or stool cultures may be 
positive, but bone marrow cultures, now very rarely done, are most sensitive. If either 
diagnosis is suspected, patients may be treated with broad-spectrum antibiotics,22 including 
a quinolone (there may be some resistance to these), azithromycin, or a third-generation 
cephalosporin until a diagnosis is confirmed.
The CDC recommends typhoid fever vaccine for all travelers to Brazil.22 Two vaccines are 
licensed: an inactivated injectable vaccine and a live, attenuated vaccine taken orally. Both 
provide 55% to 70% protection.23No vaccine is available for paratyphoid fever. Other 
preventive measures include food and beverage precautions (described in the 
“Gastrointestinal Illness and Travelers’ Diarrhea” section).22
Yellow Fever
Yellow fever virus is transmitted by the bite of an infected mosquito, primarily Aedes 
orHaemagogusspecies. Yellow fever virus infection is often a symptomatic; when disease 
occurs it can range from a nonspecific viral syndrome to severe disease with jaundice, 
multiorgan failure, hemorrhage, and death. Yellow fever should be suspected when an 
unimmunized traveler returns with fever from an endemic area. Clinicians suspecting yellow 
fever should contact their state or local health department or call the CDC Arboviral Disease 
Branch (Table 2). Treatment is exclusively supportive. Yellow fever vaccine is 
recommended for all travelers 9 months or older traveling to areas within Brazil with risk of 
yellow fever virus transmission (Figure 1A).24,25The live, attenuated yellow fever vaccine is 
rarely associated with serious or fatal adverse events.26 Contraindications include, but are 
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not limited to, age younger than6months, allergy to any vaccine component, and altered 
immune status.25-27 Precautions include age 6 to 8 months, age 60 years or older, a 
symptomatic human immunodeficiency virus infection with moderate immune suppression, 
pregnancy, and breastfeeding.25 Clinicians should review each traveler’s medical history 
and itinerary to evaluate risk of yellow fever disease vs risk from vaccine. The online 
Yellow Fever Vaccination Center Registry lists US clinics authorized to administer vaccine 
(http://wwwnc.cdc.gov/travel/yellow-fever-vaccination-clinics/search). Clinicians should 
educate travelers on preventive measures against mosquito bites, including using insect 
repellents, wearing long-sleeved permethrin-treated clothing, choosing rooms with air 
conditioning or intact screens, and sleeping under an insecticide-treated bed net.28
Meningococcal Disease
Caused by Neisseria meningitidis, meningococcal disease is endemic in Brazil. 
Meningococcal disease, characterized by headache, fever, stiff neck, nausea, and altered 
mental status, can result in severe disease and death.29 Outbreaks in Brazil have been 
primarily due to serotypes B and C.30 Travelers suspected of having meningitis should be 
treated aggressively with broad-spectrum antibiotic coverage, such as third-generation 
cephalosporin and vancomycin. Vaccines currently available in the United States are not 
protective against serogroup B.30 Because N meningitides is transmissible via close contact 
with respiratory secretions, travelers staying in crowded housing (eg, hostels) may benefit 
from a meningococcal conjugate vaccine.
Rabies
Rabies is an acute, progressive, fatal encephalomyelitis that is endemic in Brazil.31 Illness 
generally occurs after a bite from a rabid mammal; nonbite transmissions are rare but can 
occur, such as via aerosol from bats in caves.32 The CDC recommends the preexposure 
vaccination of 3 doses (administered on days0, 7, and 21 or 28) for some travelers, including 
those who might be in direct contact with bats or stray animals.31Review of a traveler’s 
itinerary may help identify potential exposures, such as a trip that involves handling animals 
in the Amazon rain forest.33The CDC does not recommend that travelers begin the 3-dose 
series if they are unable to complete it before departure. Because preexposure vaccine is not 
entirely protective31 and the disease highly fatal, health care practitioners should educate 
travelers about animal avoidance and the importance of prompt health care for postexposure 
prophylaxis and immediate and thorough wound cleaning with soap and water should any 
bite occur.
Malaria
Malaria is transmitted by mosquito bites (Anopheles species). Infection, characterized by 
fever, chills, headache, myalgia, and malaise, can result in severe illness and death.34 Nearly 
all malaria cases in Brazil occur in the Amazon region, where the 2014 World Cup host 
cities Cuiaba and Manaus are located (Figure 1A).24,35
Medical practitioners should advise travelers about malaria chemoprophylaxis based on 
travel itineraries. Because of widespread chloroquine resistance in Brazil, atovaquone–
proguanil hydrochloride (Malarone; GlaxoSmithKline), doxycycline, or mefloquine 
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hydrochloride (Lariam [Roche] and generic) are recommended for chemoprophylaxis.24 
Determination of which medication to use is based on age, underlying medical conditions, 
and cost.34 Travelers should follow the mosquito bite prevention measures detailed in the 
“Yellow Fever” section. The Department of State (http://www.usembassy.gov) and some 
travel health insurance companies can assist with identifying local medical services for 
travelers who develop a fever while traveling. Health care practitioners should inform 
travelers to urgently seek medical care if they develop fever following travel to a malaria-
endemic area. A rapid malaria antigen detection test along with three blood smears at 8-hour 
intervals should be evaluated for parasites. Assistance in diagnosis and treatment can be 
obtained from an infectious diseases or tropical medicine clinician, as well as from the CDC 
malaria branch (Table 2).
Dengue
Dengue is endemic to Brazil and is transmitted by the bite of a mosquito (primarily 
Aedesaegypti). Aedes mosquitoes feed during the day and typically live indoors in dark, cool 
places.36 More than 4 million cases of dengue were reported in Brazil during 1986 through 
2006.37 Patients may have a mild, nonspecific febrile syndrome with headache and myalgia, 
although up to 5% may develop severe, life threatening disease with hemorrhagic signs and 
symptoms.36 Treatment is supportive; early recognition of severe dengue is critical to 
reducing morbidity. Neither a vaccine nor chemoprophylaxis is available to prevent dengue. 
Healthcare practitioners should educate travelers on the mosquito bite prevention measures 
previously described.
Gastrointestinal Illness and Travelers’ Diarrhea
PathogenssuchasEscherichiacoli,Campylobacterspecies,Giardiaspecies, and norovirus are 
common causes of travelers’ diarrhea.38,39 A review of ill travelers returning from Brazil 
between 1997 and 2013 found that gastrointestinal illness accounted for 34% of all 
diagnoses.40Healthcare practitioners should educate travelers on the importance of frequent 
handwashing with soap and water and use of alcohol-based hand sanitizers to decrease their 
risk of gastrointestinal illness.39,41 Other recommended approaches to reduce risk include 
food and water precautions and the use of nonantimicrobial drugs for prophylaxis.39 Freshly 
cooked food that is served hot is less likely to be contaminated than foods that have been 
sitting out. Travelers should avoid raw foods, such as salads, unpeeled fruits, or uncooked 
vegetables. Tap water may contain viruses, bacteria, or parasites and may be unsafe for 
drinking, preparing food, or for making ice. Travelers may choose to boil, filter, or 
otherwise treat water for consumption, although this may not remove chemical 
contaminants.41 Choosing unopened, factory-sealed beverages and avoiding ice in drinks 
may decrease the risk of travelers’ diarrhea.
Travelers’ diarrhea usually resolves within 48 hours.39 Ill travelers should maintain a high 
intake of nonalcoholic fluids to prevent dehydration and avoid dairy products. The 
effectiveness of a singledose or 3 days of antibiotic therapy with a fluoroquinolone or 
azithromycin, along with over-the-counter loperamide hydrochloride to ease symptoms, 
iswell established for self-treatment. Bismuth subsalicylate, the active ingredient in Pepto-
Bismol (Procter & Gamble), is a nonantimicrobial drug useful for mild travelers’ diarrhea if 
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it has not been used for prophylaxis. Health care practitioners should review a traveler’s 
medical history as those taking anticoagulants, probenecid, or methotrexate and travelers 
with aspirin allergy, renal insufficiency, and gout should avoid taking bismuth 
subsalicylate.39
If travelers’ diarrhea does not resolve, is not responsive to self-treatment, or is accompanied 
by high fever or bloody diarrhea, travelers should immediately seek medical attention. 
Because travelers’ diarrhea leads to fluid and electrolyte loss, oral rehydration salts should 
be considered if diarrhea and/or vomiting occur. Both bismuth subsalicylate and rehydration 
salts are widely available at stores and pharmacies.39
Leishmaniasis
Leishmaniasis is caused by the protozoan parasite Leishmania species, spread primarily 
through the bite of infected sand flies.42 It has rarely been seen in travelers returning from 
Brazil.40 The most common form of leishmaniasis in travelers is a dermatologic infection 
called cutaneous leishmaniasis, which is characterized by skin lesions that may develop 
weeks or months after infection as small papules or nodular plaques, progressing to ulcers 
that may scale or crust (Figure 2). No vaccines or drugs are available to prevent 
leishmaniasis; healthcare practitioners should educate travelers on vector prevention 
practices, such as those described in the yellow fever section. Diagnosis usually involves 
identification of the parasites in a skin biopsy. A number of treatment regimens are available 
depending on the species identified. See Table 2 for medical practitioner resources.
Schistosomiasis
Schistosomiasis is caused by Schistosoma species parasites. Infection occurs when the larval 
form penetrates the skin, typically when a person swims or bathes infresh water.43 Brazil is 
endemic for schistosomiasis, and outbreaks have been reported, including one in the 2014 
World Cup site of Belo Horizonte.44 Patients with acute schistosomiasis (Katayama 
syndrome) may have fever, headache, myalgia, diarrhea, painful hepatomegaly or 
splenomegaly, and respiratory symptoms.45 Diagnosis is confirmed by microscopic 
identification of parasite eggs in stool or urine or by serological testing. Serological testing 
should be done at least 3 months following exposure. Referral to someone with expertise in 
treating schistosomiasis is recommended (Table 2).43,45
Leptospirosis
Leptospirosis is a bacterial infection transmitted through breaks in the skin or through 
conjunctiva and mucous membranes via contact with urine or reproductive fluids from 
infected animals or by contact with water or soil contaminated by these fluids.46 Symptoms 
include an acute febrile illness with headache (potentially severe with retroorbital pain and 
photophobia), which can progress to severe disease (Weil disease). Diagnosis is typically 
based on clinical recognition of the often biphasicillness. Blood, urine, or spinal fluid 
cultures may yield results, along with serological testing. Nucleic acid amplification 
(polymerase chain reaction) may also be available.46 Treatment includes antibiotics such as 
penicillins and tetracyclines (Table 2).
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Dermatologic issues are common among travelers to Brazil.40Wearing appropriate clothing 
and using insect repellent can limit insect bites.28 The use of high–UV protection factor (UV 
protection factor >30) sunscreen and clothing is recommended to prevent sunburn.47
Bed bugs (Cimex lectularius) are common worldwide; infestations can occur in hotels.28,48 
Travelers who see evidence of bed bugs, such as blood spotting on bed linens or the bugs 
themselves (reddish brown, 1-7mmlong) should request alternate lodging.28
Cutaneous larva migrans, known as hookworm, is transmitted via contaminated soil or sand 
and has been documented in travelers to Brazil.40,49,50 Infected travelers may have a 
creeping eruption (Figure 2). Most often, skin on the foot and buttocks is affected. Larva 
migrans can be treated by using albendazole or ivermectin.50,51 Travelers can reduce their 
risk of infection by wearing shoes and using barriers (eg, towels) when sitting on the 
ground.50 Various treatment regimens exist, most notably oral albendazole or ivermectin.
Tungiasis is caused by the flea Tunga penetrans. These parasites become embedded in the 
epidermis, where they mature and produce eggs until their death up to 5 weeks later (Figure 
2). Because the fleas remain partially extruded from the skin, pathogens can enter through 
the break in the skin. The periungual regions of the toes are the preferred penetration site of 
T penetrans, but they can penetrate skin anywhere on the body.52 Tungiasis is common in 
impoverished areas of Brazil.53Wearing closed-toe shoes may limit exposure; treatment 
requires extraction of the parasite.
Sexually Transmitted Infections
A systematic review of studies of travel-associated sexual behavior calculated a pooled 
prevalence of 20.4% for casual sex, of which 49.4% is unprotected.54 Health care 
practitioners should advise travelers to avoid unprotected sex with new partners while 
traveling. Condoms can decrease risk and should be purchased prior to departure to ensure 
they are of sufficient quality. Assessment of a traveler with a suspected sexually transmitted 
disease includes screening for others such as human immunodeficiency virus and hepatitis 
B.
Psychological Stress and Mental Health
Travel may lead to psychological stress, which can intensify symptoms in persons with 
preexisting mental health conditions such as depression or anxiety disorders.55,56 Health 
care practitioners should consider psychiatric history, recent life stressors, and the use of any 
medication that may have adverse central nervous system effects. People with preexisting 
mental health conditions should not use mefloquine for malaria chemoprophylaxis because 
this may have adverse effects.34,55
Safety and Security Issues
The crime rate is high inmost of urban Brazil, with murder and other crime rates more than 4 
times higher than in the United States.57 Travelers are often the targets of street crime, 
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especially during evening hours. A review of general safety issues when traveling has been 
published elsewhere.58 Before beginning international travel, US citizens should register 
their itineraries with the Smart Traveler Enrollment Program (STEP), a free service that 
allows the US Department of State to better assist travelers in the event of an emergency; 
travelers can enroll online at https://step.state.gov/step/.
Road Safety
In 2008, 39 211 deaths due to road traffic were documented in Brazil.59 The Brazilian 
federal government maintains a Portuguese language website with information on road 
conditions and downloadable roadmaps.60,61Travelers who drive should familiarize 
themselves with local laws. Traffic signs may be written in Portuguese. Travelers should 
ensure all cars include basic safety equipment, such as seat belts, which should always be 
worn. Travelers can dial 190 to seek assistance from local police departments; this service is 
in Portuguese only.57
Pretravel and Posttravel Health Care and Travel Insurance
Travelers to Brazil should visit a medical practitioner for a pretravel consultation 4 to 6 
weeks before departure. Consultations should include a review of the traveler’s medical 
history and itinerary, administration of immunizations and chemoprophylaxis, and 
discussion of other preventive measures.62 Health care practitioners who are not comfortable 
providing pretravel consultations or who do not have necessary vaccines in stock should 
refer patients to a travel medicine specialist63; a listing of travel clinics is available online at 
http://www.istm.org.For the most current health information, health care practitioners can 
visit the CDC Travelers’ Health website (http://wwwnc.cdc.gov/travel) or review CDC’s 
Yellow Book online (http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014).
Before departure, travelers should contact their health insurance company to determine 
whether their policy includes coverage overseas and for emergency expenses such as 
aeromedical evacuation. Travelers are advised to consider supplemental travel health 
insurance with specific overseas coverage, including 24-hour access to assistance for health 
care and medical evacuation contingency plans.64,65
Travelers who become sick or injured while traveling should seek immediate health care if 
they have fever, diarrhea with high fever, bloody diarrhea, or an animal bite or scratch or 
have been involved in an automobile accident or assaulted. Several illnesses associated with 
fever, including malaria, dengue, influenza, and typhoid fever, can become symptomatic in 
the first 2weeks on returning from travel.66,67
Conclusions
Travel to Brazil for mass gatherings has potential health risks. Travelers should consult their 
health care practitioner 4 to 6weeks before travel. Because health advice may need to be 
adapted quickly in response to environmental conditions, disease outbreaks, and political 
situations, the CDC recommends that travelers seek up-to-date health and safety information 
at http://wwwnc.cdc.gov/travel. Lastly, travelers who develop fever during or after travel to 
Gaines et al. Page 8













Brazil should immediately seek health care. Health care practitioners should ask patients 
presenting with illness about any travel history.
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Figure 1. Venue Maps
A, Fédération Internationale de Football Association (FIFA) World Cup host cities with 
areas with malaria transmission and where yellow fever vaccine is recommended, Brazil, 
2014. B, Venues for 2016 Olympic and Paralympic Games.
aCDC Health Information for International Travel, 2014.
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Figure 2. Dermatologic Conditions Found in Brazil
Crater ulcers of various stages due to cutaneous leishmaniasis on the arm (A) (source: 
Centers for Disease Control and Prevention/Mae Melvin, MD); cutaneous larvamigrans (B) 
(source: Jay Keystone, University of Toronto); and tungiasis (C) (source: Mohammed 
Asmal and RocioM. Hurtado [this image was first published on Partners’ Infectious Disease 
Images website, whose content is copyrighted by Partners Healthcare System Inc and is used 
with permission. All rights reserved]).
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Table 1
Routine Vaccine Recommendations for Travelers to Brazil, Advisory Council for Immunization Practices, 
2013
Vaccine Acceptable Presumptive Evidence of Immunity Recommendations for International Travelers
Influenza12 Because of seasonal variation in circulating influenza 
strain, annual immunizations are needed.
All travelers should receive seasonal influenza 
vaccine unless contraindicated.
MMR13 Adults born before 1957. Laboratory evidence of 
immunity OR laboratory confirmation of disease.
Children aged 6-11 mo should receive 1 dose of 
MMR vaccine.
Documentation of age-appropriate vaccination with a 
live measles virus-containing vaccine.
Children aged ≥12 mo and adults should receive 2 
doses of MMR vaccine separated by at least 28 d if 
not previously immunized.
Tetanus, diphtheria, pertussis14 Documentation of age-appropriate vaccination for 
tetanus, diphtheria, pertussis.
Children aged 11-18 y should receive 1 dose of 
tetanus toxoid, reduced Tdap vaccine.
All adults who have not previously received Tdap 
vaccine should receive 1 dose.
Adults aged ≥19 y who have received 1-time dose 
of Tdap vaccine should receive booster with Td 
vaccine every 10 y afterwards.
Varicella15 History of varicella or herpes zoster based on 
diagnosis by a health care practitioner.
2 doses of vaccine ≥4 wk apart for persons aged ≥13 
y.
Laboratory evidence of immunity OR laboratory 
confirmation of disease.
Documentation of vaccination.
Abbreviations: MMR, measles, mumps, rubella; OR, operating room; Td, tetanus and diphtheria; Tdap, combined tetanus, diphtheria, and pertussis.
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Table 2
Diagnostic and Treatment Resources for Health Care Practitioners
Resource Contact Information Assistance Available
American Society of Tropical 
Medicine and Hygiene
http://www.astmh.org/Home1.htm Identify a nearby physician with clinical 
consultative service in tropical medicine, 
medical parasitology, travelers’ health
CDC’s Arboviral Diseases 
Branch
Telephone: 970-221-6400 Yellow fever diagnostic testing; assessment 
of antibody response to yellow fever 
vaccination
CDC’s Dengue Branch Telephone: 800-232-4636 or 888-232-6348 http://
www.cdc.gov/Dengue/
Clinical and laboratory guidance for 
dengue; resources for clinicians and 
laboratorians
International Society of 
Travel Medicine
http://www.istm.org TravelMed listserv allows discussion of 
clinical cases, pretravel and posttravel 
medical issues; identify a nearby physician 
with expertise in travelers’ health, and 
some with tropical medicine experience
CDC’s Malaria Branch EST working hours, Monday-Friday: CDC Malaria Hotline at 
770-488-7788 or 855-856-4713; After hours: Emergency 
Operations Center: 770-488-7100
Malaria diagnostics; treatment of malaria.
CDC’s Parasitic Disease 
Inquiries
Telephone: 404-718-7475 http://www.cdc.gov/parasites Diagnostics for leishmaniasis, 
schistosomiasis; treatment for 
leishmaniasis, schistosomiasis
CDC’s Travelers’ Health 
Branch
http://wwwnc.cdc.gov/travel Access CDC Health Information for 
International Travel 2014 online
Abbreviation: CDC, Centers for Disease Control and Prevention.
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